The World Health Organization (WHO) has updated its global clinical guidelines regarding the management of childhood obesity. The new recommendations explicitly advise against the use of weight-loss drugs, such as injectable medications, for children under the age of 10. Health officials stress that the primary approach for managing weight in this age group should be centered on lifestyle interventions, specifically the promotion of healthy dietary habits and increased physical activity.

While the use of pharmacological interventions for obesity has grown significantly in adult populations, the WHO’s stance reflects a cautious approach toward applying these treatments to younger children. The guidance suggests that the focus for children under 10 must remain on behavioral and environmental changes rather than medical or pharmaceutical solutions. This shift aims to ensure that children develop sustainable health habits during their formative years, rather than relying on medical intervention to manage body weight.

The WHO’s position is intended to provide a standardized framework for healthcare providers globally, though the implementation of these guidelines may vary depending on local health policies and the availability of resources. By emphasizing non-medical interventions, the organization seeks to mitigate potential long-term side effects and prioritize holistic health outcomes for children. The guidelines do not explicitly detail the specific medical risks for children under 10, but the recommendation serves as a clear directive for pediatric care standards worldwide.